Jakafi

Incyte pancreatic cancer drug improves survival in mid-stage trial
Reuters
Wed, 08/21/13 - 10:18 am
Incyte
pancreatic cancer
Jakafi
Is This Myelofibrosis Drug a Blockbuster?
Motley Fool
Sat, 08/17/13 - 10:36 am
myelofibrosis
Jakafi
Incyte
Incyte Drug Jakafi® (ruxolitinib) Improved Overall Survival in Phase III Trial of Patients with Myelofibrosis
Yahoo/BusinessWire
Sun, 06/16/13 - 11:33 am
Incyte
clinical trials
Jakafi
myelofibrosis
Incyte Jakafi outlook still positive after label revisions, says Oppenheimer
Yahoo/Fly on the Wall
Thu, 06/13/13 - 10:31 am
Incyte
Jakafi
Incyte discloses patient treated with ruxolitinib develops PML
The Fly on the Wall
Mon, 03/18/13 - 10:56 am
Incyte
PML
ruxolitinib
Jakafi
Incyte's Jakafi Is Likely A $1 Billion Drug
Seeking Alpha
Thu, 02/28/13 - 11:35 am
Jakafi
Incyte
myelofibrosis
Incyte Pharmaceuticals Is Primed For A Run
Seeking Alpha
Tue, 02/5/13 - 10:54 am
Incyte
Novartis
Eli Lilly
Jakafi
Incyte looks to ride on drug's success
The News Journal, DE
Sun, 05/6/12 - 11:44 am
Incyte
Jakafi
myelofibrosis
polycythemia
Incyte CEO Touts Prospects of New Cancer Drug
Minyanville
Sat, 11/19/11 - 11:38 am
Jakafi
Incyte
myelofibrosis
F.D.A. Approves Drug for Bone Marrow Disease
NY Times, NY
Thu, 11/17/11 - 09:09 am
FDA
myelofibrosis
bone marrow disorder
Jakafi
JAK inhibitors
Incyte

Pages